Novan Announces Strategic Priorities and Outlines Key Milestones

NASDAQ Market News

NEXT STORY
Centessa Pharmaceuticals Announces Positive Topline Data from Proof-of-Concept Study of SerpinPC in Severe Hemophilia A and B Patients Not on Prophylaxis
PREV STORY
Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19

author_avatar
NASDAQ Market News

iCAD Responds to CMS’ Finalized Radiation Oncology Alternative Payment Model

author_avatar
NASDAQ Market News

Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2 Diabetes and Persistent High Triglycerides

BEDMINSTER, N.J. and DUBLIN, Ireland, June 12, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), ...

author_avatar
NASDAQ Market News